REFERENCES
- Abrahamsson B., Alpsten M., Bake B., Larsson A., Sjogren J. In vitro and in vivo erosion of two different hydrophilic gel matrix tablets. Eur. J. Pharm. Biopharm. 1998; 46(1)69–75
- Avdeef A., Strafford M. A., Brownell C. R., Lyon R., Artursson P., Johansson C. A. S., Luthman K. Determination of Drug Solubility using a Potentiometric Acid-Base Titration Method compared to the Saturation Shake-Flask Method. AAPS PharmSci. 2000; 2(1), Abstract 2217.
- Baumgartner S., Lahajnar G., Sepe A., Kristl J. Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods. Eur. J. Pharm. Biopharm. 2005; 59(2)299–306
- Beckers E. J., Leiper J. B., Davidson J. Comparison of aspiration and scintigraphic techniques for the measurement of gastric emptying rates of liquids in humans. Gut 1992; 33(1)115–117
- Bernier J. J., Adrian V. Les aliments dans le tube digestif. Doin Editeurs, Paris 1988
- Blanquet S., Antonelli R., Laforet L., Denis S., Marol-Bonnin S., Alric M. Living recombinant Saccharomyces cerevisiaesecreting proteins or peptides as a new delivery system in the gut. J. Biotechnol. 2004a; 110(1)37–49
- Blanquet S., Zeijdner E., Beyssac E., Meunier J-P., Denis S., Havenaar R., Alric M. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm. Res. 2004b; 21(4)585–591
- Chung Y. C., Kim A., Shadchehr A., Garrido I. L., Macgregor M., Sleisenger H. Protein digestion and absorption in human small intestine. Gastroenterology 1979; 76: 1415–1421
- Christensen G. L., Dale L. B. U.S. Patent. 3,065,143, 1962
- Dressman J. B., Amidon G. L., Reppas C., Shah V. P. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 1998; 15(2)11–22
- Ford J. L., Rajabi-Siahboomi A. R. Dissolution and dissolution testing. Encyclopedia of pharmaceutical technology. Marcel Dekker, New York 2002
- French national drug compendium “VIDAL”, 80thedition, Vidal Edition, Issy les Moulineaux, 2004.
- Galia E., Nicolaides E., Horter D., Lobenberg R., Reppas C., Dressman J. F. Evaluation of various dissolution media for predcting in vivo performance of class I and II drugs. Pharm. Res. 1995; 15(5)698–705
- Havenaar R., Minekus M. In vitro model of an in vivo digestive tract. JP, US, European Patent PCT/NL 93/00225, 1994
- Melia C. D. Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit. Rev. Ther. Drug Carrier Syst. 1991; 8(4)395–421
- Minekus M., Marteau P., Havenaar R., Hui J. H. A multi compartmental dynamic computer-controlled model simulating the stomach and small intestine. Alta. 1995; 23(2)197–209
- Moller H. Evaluation of sustained release dosage forms of theophylline by measurement of in vitro and in vivo release. Xcerpta Medica, Amsredam 1983
- Murray R., Eddy D. E., Bartoili W. P., Paul G. L. Gastric emptying of water and isocratic carbohydrate solutions consumed at rest. Med. Sci. Sports. Exerc. 1993; 26(4)725–732
- Roy D. S., Rohera B. D. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur. J. Pharm. Sci. 2002; 16(3)193–199
- Souliman S., Blanquet S., Beyssac E., Cardot J-M. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur. J. Pharm. Sci. 2006; 27(1)72–79
- Sournac M., Beyssac E., Maublant J.-C., Aiache J.-M., Veyre A., Bougaret J. Scintigraphic study of the gastro-intestinal transit and correlation with the drug absorption kinetics of a sustained release Theophylline tablets. I- Administration in fasting state. J. Control. Release. 1988; 7: 139–146
- Sournac M., Beyssac E., Maublant J.-C., Aiache J.-M., Veyre A., Bougaret J. Scintigraphic study of the gastro-intestinal transit of a sustained release Theophylline tablet. II- Administration in non-fasting state. J. Control. Release. 1991; 15: 113–120
- Zahirul M., Khan I. Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities. Int. J. Pharm. 1996; 140(2)131–143